Inspire Advisors LLC Sells 207 Shares of Maximus, Inc. (NYSE:MMS)

Inspire Advisors LLC cut its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 2.3% during the 1st quarter, HoldingsChannel reports. The firm owned 8,647 shares of the health services provider’s stock after selling 207 shares during the period. Inspire Advisors LLC’s holdings in Maximus were worth $725,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in MMS. Rise Advisors LLC grew its holdings in Maximus by 1,445.0% during the 1st quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after acquiring an additional 289 shares during the last quarter. Anchor Investment Management LLC bought a new stake in shares of Maximus in the 4th quarter valued at $32,000. Kapitalo Investimentos Ltda bought a new stake in shares of Maximus in the 4th quarter valued at $52,000. Planned Solutions Inc. acquired a new position in shares of Maximus during the 4th quarter valued at $59,000. Finally, Fifth Third Bancorp lifted its position in shares of Maximus by 57.9% during the 4th quarter. Fifth Third Bancorp now owns 998 shares of the health services provider’s stock valued at $84,000 after acquiring an additional 366 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Stock Up 2.6 %

Shares of Maximus stock traded up $2.36 during trading on Tuesday, reaching $91.68. 61,130 shares of the company traded hands, compared to its average volume of 334,839. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.53 and a quick ratio of 1.53. Maximus, Inc. has a 1-year low of $72.39 and a 1-year high of $91.97. The company has a 50 day moving average price of $86.13 and a 200-day moving average price of $83.41. The firm has a market capitalization of $5.57 billion, a PE ratio of 24.10 and a beta of 0.75.

Maximus (NYSE:MMSGet Free Report) last released its earnings results on Wednesday, May 8th. The health services provider reported $1.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.26. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the company earned $0.80 EPS. Maximus’s quarterly revenue was up 11.7% compared to the same quarter last year. As a group, equities research analysts expect that Maximus, Inc. will post 5.79 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.31%. Maximus’s payout ratio is 31.50%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.